Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Report: The Evolution of Healthcare – Laboratory Transformation

Report: The Evolution of Healthcare – Laboratory Transformation
The latest insights on laboratory studies, including laboratory leadership, AI and quality in haematology.

In this report we reveal perspectives shared by experts of the industry, including how leaders in the laboratory are navigating change, what shifting to value-based healthcare means for the laboratory, what pathologists make of artificial intelligence in the lab, and COVID-19's impact on thrombosis.

Here are some key points to take away from this report:

  • "The days of the pathologist sitting all day looking at slides are at an end." - Dr. Kadria Sayed at Medlab Middle East 2021.
  • "Pathologists are the ones deciding on what’s important to study. Human operators will still be required to program the AI, validate and verify its performance." - Dr. Aaron Han at Medlab Middle East 2021.
  • The most frequent type of thrombosis is deep vein thrombosis (DVT) and pulmonary embolism. The other types of thrombosis are rare such as splanchnic vein thrombosis (SVT) and cerebral veins thrombosis.
Click to read The Evolution of Healthcare – Laboratory Transformation